zm 241385 has been researched along with egtazic acid in 2 studies
| Studies (zm 241385) | Trials (zm 241385) | Recent Studies (post-2010) (zm 241385) | Studies (egtazic acid) | Trials (egtazic acid) | Recent Studies (post-2010) (egtazic acid) |
|---|---|---|---|---|---|
| 401 | 3 | 124 | 10,021 | 11 | 686 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Easton, AS; Inglis, VI; Jones, MP; Tse, AD | 1 |
| Konishi, S; Rusakov, D; Saitow, F; Satake, S | 1 |
2 other study(ies) available for zm 241385 and egtazic acid
| Article | Year |
|---|---|
Neutrophils both reduce and increase permeability in a cell culture model of the blood-brain barrier.
Topics: Adenosine; Adenosine Deaminase; Animals; Aprotinin; Blood-Brain Barrier; Capillary Permeability; Catalase; Cell Culture Techniques; Cell Movement; Cells, Cultured; Egtazic Acid; Electric Impedance; Endothelial Cells; Free Radicals; Humans; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Superoxide Dismutase; Triazines; Triazoles | 2004 |
AMPA receptor-mediated presynaptic inhibition at cerebellar GABAergic synapses: a characterization of molecular mechanisms.
Topics: Action Potentials; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Benzothiadiazines; Benzoxazines; Calcium; Calcium Channel Blockers; Cerebellum; Chelating Agents; Colforsin; Cyclopropanes; Drug Interactions; Egtazic Acid; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; GABA Antagonists; gamma-Aminobutyric Acid; Glycine; In Vitro Techniques; Morpholines; Naphthalenes; Neural Inhibition; Neurons; Piperidines; Presynaptic Terminals; Pyrazoles; Rats; Rats, Wistar; Receptors, AMPA; Ryanodine; Synapses; Triazines; Triazoles | 2004 |